Professor Usha Menon

Citado por

	Total	Desde 2020
Citas	40538	19373
Índice h	90	62
Índice i10	340	257

4200

2100

1050

3150

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025124 163 234 310 383 384 494 685 861 1102 1400 1556 1858 2366 2598 2825 3064 3742 3760 4108 3410 3771 543

Acceso público

Ver todo

329 artículos

8 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Ian JacobsPresident & Vice Chancellor, University of New South Wales, Sydney, AustraliaDirección de correo verificada de unsw.edu.au
Ranjit ManchandaProfessor of Gynaecological Oncology and Consultant Gynaecological OncologistDirección de correo verificada de qmul.ac.uk
Steven SkatesMassachusetts General HospitalDirección de correo verificada de mgh.harvard.edu
John F. TimmsUniversity College LondonDirección de correo verificada de ucl.ac.uk
Susan RamusUniversity of New South WalesDirección de correo verificada de unsw.edu.au
alexey zaikinProfessor, University College LondonDirección de correo verificada de ucl.ac.uk
Anne LanceleyProfessor of Women's Cancer CareDirección de correo verificada de ucl.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsDirección de correo verificada de lse.ac.uk
Saskia SandersonData Science Lead, UK Mental Health Mission, and Senior Research Fellow, King's College LondonDirección de correo verificada de kcl.ac.uk
Robert BastMD Anderson Cancer CenterDirección de correo verificada de mdanderson.org
Evans DG*, Evans G*University of ManchesterDirección de correo verificada de mft.nhs.uk
Lesley J. FallowfieldDirector SHORE-C, University of SussexDirección de correo verificada de sussex.ac.uk
Stephen PereiraUniversity College LondonDirección de correo verificada de ucl.ac.uk
Paul PharoahCedars-Sinai Medical CenterDirección de correo verificada de cshs.org
Andrew TeschendorffCAS Key Lab of Computational Biology, Shanghai Institute of Nutrition and Health, ShanghaiDirección de correo verificada de sinh.ac.cn
Rainer CramerProfessor of Mass Spectrometry and Bioanalytical SciencesDirección de correo verificada de reading.ac.uk
Ali TISSDasman Diabetes InstituteDirección de correo verificada de dasmaninstitute.org
Alexander GammermanProfessor of Computer Science, Royal Holloway University of LondonDirección de correo verificada de rhul.ac.uk
Nazar N Amso PhD, FRCOG, FHEAEmeritus Professor, Cardiff UniversityDirección de correo verificada de cardiff.ac.uk
Peter SasieniProfessor of Cancer Prevention, King's College LondonDirección de correo verificada de kcl.ac.uk

Seguir

Professor Usha Menon

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College

Dirección de correo verificada de ucl.ac.uk - Página principal

Cancer screening diagnosis risk prediction Biomarkers


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011	1573	2011
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1496	2017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015	1281	2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016	1249	2016
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer The lancet oncology 13 (11), 1141-1151, 2012	1239	2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012	1146	2012
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	1064	2019
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009	1062	2009
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ... Genome research 20 (4), 440-446, 2010	972	2010
Management of women who test positive for high-risk types of human papillomavirus: the HART study J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ... The Lancet 362 (9399), 1871-1876, 2003	771	2003
Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999	735	1999
Progress and challenges in screening for early detection of ovarian cancer IJ Jacobs, U Menon Molecular & Cellular Proteomics 3 (4), 355-366, 2004	693	2004
New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005	684	2005
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013	662	2013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021	578	2021
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015	531	2015
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013	492	2013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	463	2017
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013	427	2013
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901-2907, 2015	415	2015

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores